Hyperglycemia-induced ROS (reactive oxygen species) overproduction is a major contributor to chronic low-grade inflammation, the activated NLRP3 inflammasome becoming a key in the pathogenesis of metabolic disturbances characteristic for CMS [32,34]. This evidence concerns the gene NLRP3 and Hyperglycemia.